The DCRI Podcast: Science is the Best Medicine
The world of clinical research is constantly changing, as new scientific discoveries open up new avenues for patient care. In the Science is the Best Medicine podcast, DCRI Fellow Abhinav Sharma, MD, speaks with the scientists and physicians on the cutting edge of clinical research to keep you abreast of the latest developments.
Chronic kidney disease (CKD) is among the most common diseases in the United States, affecting approximately 14 percent of the adult population. The disease, which often goes unnoticed until its advanced stages, can increase the risk of heart attack, stroke, or other serious medical conditions. In this episode of Science is the Best Medicine, Abhinav Sharma, MD, talks with DCRI Co-Chief Fellow John Stanifer, MD, Msc, about his work with CKD research in East Africa and rural North Carolina.
Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result, according to the Centers for Disease Control. These so-called "superbugs" represent one of the major public health threats facing the world today. In this episode, Ephraim Tsalik, MD, PhD, discusses the rise of superbugs and how researchers are trying to find new ways to fight them.
Robert Lefkowitz, MD, won the Nobel Prize for Chemistry in 2012 for his groundbreaking work on the proteins known as receptors. That research has since influenced the development of a wide variety of drugs including antihistamines, ulcer drugs, and beta blockers. In this episode of the podcast, he discusses his research, his family, and the path that brought him to Duke.
Medicare, Obamacare, rising costs, and preexisting conditions: The controversy over health care in the United States rages on in Congress and online. In this episode Mark McClellan, MD, PhD, director of the Margolis Center for Health Policy and former U.S. Food and Drug Administration commissioner, discusses the complexities of healthcare policy.
What are clinical trials? Who should participate in them? And why are they important? In this episode of Science is the Best Medicine, Abhinav Sharma talks to Harvard’s Eugene Braunwald, MD, a cardiologist who’s been a firsthand witness to more than 50 years of clinical trials.